gliclazide has been researched along with Pneumonia, Viral in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh Tomar, PP | 1 |
| Arkin, IT | 1 |
1 other study available for gliclazide and Pneumonia, Viral
| Article | Year |
|---|---|
SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Envelope Proteins; Coronavirus Infections; COVID-19; | 2020 |